The difference...is mostly due to portfolio allocations. Larger endowments invest in riskier and higher-yielding assets compared to more conservative investments by smaller endowments.

The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.